Methods and compositions for the treatment of rare diseases
US-2025099624-A1 · Mar 27, 2025 · US
This page is not indexed by search engines while we improve data quality.
Wechsler Thomas patents
Wechsler Thomas is listed as an inventor on 20 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Wechsler Thomas |
| Total patents | 20 |
| First publication | Jun 11, 2015 |
| Latest publication | Mar 27, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Methods and compositions for the treatment of neurologic disease
US-2023330195-A1 · Oct 19, 2023 · US
Methods and compositions for nuclease-mediated targeted integration of transgenes into mammalian liver cells
US-2023203540-A1 · Jun 29, 2023 · US
Method of making and using mammalian liver cells for treating hemophilia or lysosomal storage disorder
US-11591622-B2 · Feb 28, 2023 · US
Methods and compositions for genome engineering
US-2021188926-A1 · Jun 24, 2021 · US
Methods and compositions for genome engineering
US-10968261-B2 · Apr 6, 2021 · US
Methods and compositions for enhancing targeted transgene integration
US-10889834-B2 · Jan 12, 2021 · US
Delivery methods and compositions for nuclease-mediated genome engineering
US-2020102577-A1 · Apr 2, 2020 · US
Methods and compositions for nuclease-mediated targeted integration
US-2019352671-A1 · Nov 21, 2019 · US
Delivery methods and compositions for nuclease-mediated genome engineering
US-10450585-B2 · Oct 22, 2019 · US
Recent patents
Latest publications not already listed above.
Method of treating factor IX deficiency using nuclease-mediated targeted integration
US-10370680-B2 · Aug 6, 2019 · US
Methods and compositions for the treatment of rare diseases
US-2019167815-A1 · Jun 6, 2019 · US
Methods and compositions for enhancing nuclease-mediated gene disruption
US-10227610-B2 · Mar 12, 2019 · US
Methods and compositions for genome engineering
US-2018362601-A1 · Dec 20, 2018 · US
Methods and compositions for genome engineering
US-10081661-B2 · Sep 25, 2018 · US
Methods and compositions for the treatment of neurologic disease
US-2017202931-A1 · Jul 20, 2017 · US
Delivery methods and compositions for nuclease-mediated genome engineering
US-2017016027-A1 · Jan 19, 2017 · US
Methods and compositions for enhancing targeted transgene integration
US-2016168593-A1 · Jun 16, 2016 · US
Methods and compositions for nuclease-mediated targeted integration
US-2015240263-A1 · Aug 27, 2015 · US
Methods and compositions for genome engineering
US-2015159172-A1 · Jun 11, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Sangamo Therapeutics Inc | 16 |
| Sangamo Biosciences Inc | 7 |
| Univ Minnesota | 2 |
| Sigma Aldrich Co Llc | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C12N2750/14143 | 14 |
| A61P43/00 | 13 |
| A61P7/04 | 13 |
| C12N15/907 | 10 |
| C12N15/86 | 10 |